Kon-Kiki Pharma ApS — Credit Rating and Financial Key Figures

CVR number: 43311824
Stålmosevej 33, Vindinge 4000 Roskilde

Income statement (kDKK)

2022
2023
2024
Fiscal period length121212
Net sales
Gross profit933.211 690.401 484.45
Employee benefit expenses- 462.01- 901.40- 810.23
EBIT471.20789.00674.23
Other financial income-0.141.832.60
Other financial expenses-4.73-11.41-18.58
Pre-tax profit466.33779.43658.25
Income taxes- 103.27- 176.22- 155.03
Net earnings363.06603.21503.22

Assets (kDKK)

2022
2023
2024
Intangible assets total
Tangible assets total
Investments total
Long term receivables total
Inventories total
Current trade debtors112.7565.30218.46
Current amounts owed by group member comp.10.0011.6628.39
Current deferred tax assets11.66
Short term receivables total134.4176.96246.85
Cash and bank deposits431.25888.07722.36
Cash and cash equivalents431.25888.07722.36
Balance sheet total (assets)565.66965.03969.21

Equity and liabilities (kDKK)

2022
2023
2024
Share capital40.0040.0040.00
Shares repurchased300.00650.00519.00
Retained earnings- 300.00- 586.94- 502.73
Profit of the financial year363.06603.21503.22
Shareholders equity total403.06706.27559.49
Provisions10.00
Non-current liabilities total
Short-term deferred tax liabilities83.06167.90
Other non-interest bearing current liabilities162.60165.70241.82
Current liabilities total162.60248.76409.72
Balance sheet total (liabilities)565.66965.03969.21
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.